Management of anticoagulation for cancer-associated thrombosis in patients with thrombocytopenia: A systematic review
Descargar PDF — Management of anticoagulation for cancer-associated thrombosis in patients wi… Background: The management of anticoagulation for cancer-associated thrombosis (CAT) in patients with thrombocytopenia is controversial. Whereas some studies suggest that administration of reduced-dose low-molecular-weight heparin (LMWH) or temporary discontinuation for moderate and severe thrombocytopenia may be a safe and effective, others suggest full-dose…
